Christopher B. Prentiss, Chief Financial Officer at Adamas Pharmaceuticals Inc (ADMS), sold 2,630 shares at $4.41 ($12K) on 2021-01-20, disclosed to the SEC on 2021-01-22.
Open-market sale of $12k ADMS by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| ADMS | SELL | 2020-11-02 | $7K | — | Filing → |
| ADMS | SELL | 2020-01-23 | $8K | — | Filing → |
| ADMS | SELL | 2019-07-23 | $6K | — | Filing → |